• Dual TLR2/4 Inhibition Reduces Retinopathy Pathology in Mice

  2026-04-13

  Dayoub et al. (2024) report that novel small-molecule dual inhibitors of TLR2/4, AVR-121 and AVR-123, significantly attenuate both inflammation and pathological angiogenesis in a mouse model of oxygen-induced retinopathy. Their findings highlight the value of targeting innate immune signaling to control retinopathy of prematurity, with clear implications for translational neuroinflammation research.

• ML133 HCl in Pulmonary Vascular Remodeling: Evidence-Driven

  2026-04-13

  Explore the robust scientific underpinnings of ML133 HCl, a selective potassium channel inhibitor, in pulmonary artery smooth muscle cell proliferation research. This article offers novel protocol guidance and practical assay insights not found elsewhere.

• Brefeldin A: ATPase Inhibitor for ER Stress and Apoptosis Re

  2026-04-12

  Brefeldin A (BFA) is a potent vesicle transport inhibitor that disrupts ER-to-Golgi trafficking, induces ER stress, and promotes apoptosis in cancer cells. APExBIO's B1400 kit is widely used to study protein trafficking and cancer biology. This dossier summarizes key mechanisms, evidence, and workflow guidance for BFA research.

• HBsAg Hijacks TBK1: Suppression of IFN-I and Induction of Au

  2026-04-12

  Luo et al. (2025) reveal that hepatitis B surface antigen (HBsAg) hijacks TANK-binding kinase 1 (TBK1) to suppress type I interferon signaling and induce incomplete autophagy in hepatocytes. This mechanistic insight clarifies how HBV evades innate immunity and sustains chronic infection, with implications for future antiviral and autophagy-targeted research.

• Triacetin in Biochemical Research: Protocols, Applications &

  2026-04-11

  Triacetin (glyceryl triacetate) is rapidly emerging as a versatile lipid-related biochemical reagent in oncology, metabolic regulation, and ocular studies. This article delivers actionable protocols, advanced troubleshooting, and unique research insights, highlighting how Triacetin from APExBIO elevates assay reliability and experimental innovation.

• Angiotensin (1-7): Protocol-Driven Advances in Translational

  2026-04-11

  Angiotensin (1-7) empowers researchers with validated, precision-targeted modulation of fibrotic, inflammatory, and metabolic pathways. Leveraging APExBIO’s high-purity peptide unlocks reproducibility and versatility across renal, neuroprotective, and anti-cancer models.

• PA-824 (SKU A1736): Scenario-Driven Solutions for Reliabl...

  2026-04-10

  This article delivers a scenario-driven, evidence-based exploration of PA-824 (SKU A1736), a high-purity bicyclic nitroimidazole derivative for Mycobacterium tuberculosis research. It addresses real-world laboratory challenges with practical Q&A, guiding biomedical researchers toward reproducible, sensitive, and cost-effective anti-tuberculosis assays using PA-824. Discover how this compound—supplied by APExBIO—enables robust, data-backed experimental workflows.

• PPM-18: Advanced iNOS and NF-κB Inhibition for Next-Gen S...

  2026-04-09

  Explore the unique mechanisms and translational impact of PPM-18, a potent anti-inflammatory naphthoquinone derivative and iNOS expression inhibitor. This article offers a deep dive into PPM-18’s mechanistic action, comparative advantages, and its pivotal role in modulating inflammatory signaling pathways for advanced sepsis and immune response research.

• TAK-242 (Resatorvid): A Precision Tool for Dissecting TLR...

  2026-04-08

  Explore the advanced applications of TAK-242 (Resatorvid), a selective TLR4 inhibitor, in modulating neuroinflammation and dissecting LPS-induced cytokine pathways. This in-depth article uniquely bridges molecular mechanism, translational models, and emerging research on neuropsychiatric inflammation.

• Tubastatin A: Selective HDAC6 Inhibitor for Mechanistic a...

  2026-04-08

  Tubastatin A is a highly selective HDAC6 inhibitor used extensively in cancer biology and inflammation research. Its robust selectivity and potency enable precise dissection of epigenetic regulation and cytoskeletal dynamics. APExBIO provides Tubastatin A (SKU A4101) as a reproducible research-grade reagent.

• Deracoxib as a Next-Generation Tool for Inflammation and ...

  2026-04-07

  This thought-leadership article explores Deracoxib’s unique value as a selective COX-2 inhibitor, guiding translational researchers through its multifaceted anti-inflammatory and antitumor mechanisms. Integrating advanced mechanistic insights and strategic workflow advice, the article contextualizes Deracoxib’s role in pain and inflammation research, cancer biology, and combinatorial assay design—while drawing on current literature and APExBIO’s commitment to research excellence.

• Deracoxib: Unraveling COX-2 Selective Inhibition for Adva...

  2026-04-07

  Explore the multifaceted role of Deracoxib, a selective COX-2 inhibitor, in cancer biology and inflammation research. This in-depth article uniquely examines Deracoxib’s apoptosis-regulating mechanisms, synergy with chemotherapy, and translational relevance for canine oncology models.

• Vardenafil HCl Trihydrate: Advancing Proteoform-Selective...

  2026-04-06

  Explore how Vardenafil HCl Trihydrate—a potent, selective PDE5 inhibitor—enables next-generation research in cGMP signaling and proteoform-specific pharmacology. This article uniquely examines its molecular selectivity, implications for precision vascular research, and insights from cutting-edge proteomics.

• PA-824: Bicyclic Nitroimidazole for Drug-Resistant Tuberc...

  2026-04-06

  PA-824 empowers researchers with a high-purity, dual-action approach to combating drug-resistant Mycobacterium tuberculosis. This bicyclic nitroimidazole derivative offers robust activity via inhibition of ketomycolate biosynthesis and intracellular nitric oxide release, streamlining advanced tuberculosis drug development workflows.

• Arctigenin (SKU N2399): Reliable Solutions for Cell-Based...

  2026-04-05

  This article delivers a scenario-driven, evidence-based guide for biomedical researchers and lab technicians considering Arctigenin (SKU N2399) from APExBIO for cell viability, proliferation, and cytotoxicity workflows. It addresses real-world protocol challenges, interprets quantitative data, and compares product reliability, with direct links to protocols and primary literature. Reproducibility, pathway specificity, and practical optimization are mapped to APExBIO's high-purity Arctigenin as a robust solution.

16766 records 1/1118 page Next 12345 下5页 Last page